Kopec-Schrader E, Tindall B, Learmont J, Wylie B, Kaldor J M
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia.
AIDS. 1993 Jul;7(7):1009-13. doi: 10.1097/00002030-199307000-00016.
To determine the rate of development of AIDS, and the demographic and clinical cofactors for development of AIDS in a group of 117 people with transfusion-acquired HIV infection, who were infected between 1980 and 1985 in New South Wales, Australia.
By December 1991, 67 (57%, 95% CI 48-66%) of the study subjects had developed AIDS. The estimated median time to development of AIDS was 7.2 years from the date of infection. There was no significant difference in median age at infection or sex between individuals who did and did not develop AIDS. The median time to development of AIDS was shorter in older individuals (median time to AIDS for age groups 13-39, 40-59 and > 59 was 7.8, 7.1 and 5.4 years, respectively; P = 0.20). A significantly greater proportion of individuals who had never received treatment with zidovudine developed AIDS compared with individuals who had (P = 0.04). But in a statistical analysis which took account of the changing availability of zidovudine over time, there was no significant association between the development of AIDS and treatment with zidovudine (P = 0.44).
Consistent with other studies, age appeared to increase the rate of progression to AIDS, although not significantly so in this study.
确定1980年至1985年期间在澳大利亚新南威尔士州因输血感染艾滋病毒的117人患艾滋病的发展速率,以及患艾滋病的人口统计学和临床相关因素。
到1991年12月,67名(57%,95%置信区间48 - 66%)研究对象患上了艾滋病。从感染之日起,患艾滋病的估计中位时间为7.2年。患艾滋病和未患艾滋病的个体在感染时的中位年龄或性别上无显著差异。年龄较大的个体患艾滋病的中位时间较短(13 - 39岁、40 - 59岁和>59岁年龄组患艾滋病的中位时间分别为7.8年、7.1年和5.4年;P = 0.20)。与接受过齐多夫定治疗的个体相比,从未接受过齐多夫定治疗的个体患艾滋病的比例显著更高(P = 0.04)。但在一项考虑了齐多夫定随时间可用性变化的统计分析中,患艾滋病与齐多夫定治疗之间无显著关联(P = 0.44)。
与其他研究一致,年龄似乎增加了进展为艾滋病的速率,尽管在本研究中不显著。